Smart ECM
RESMeeting SrlEvento 494504 / Edizione 1

66Th annual meeting società italiana di cancerologia integrating evolution, ecosystems and emerging technologies to transform cancer therapy

66° convegno annuale della Società Italiana di Cancerologia per ricercatori e clinici in oncologia. Affronta evoluzione tumorale, microambiente, intelligenza artificiale, genomica spaziale, biomarcatori circolanti e oncologia di precisione. Roma, 7-9 ottobre 2026, 9 crediti ECM, quota €620.

Provider
Meeting SrlMeeting Srl (7194)
Crediti ECM
9
Costo
620,00 €
Durata
9 ore
Date
7 - 9 ottobre 2026

Razionale scientifico

Cancer is a dynamic and evolving disease. Its initiation, progression, immune escape, and therapy resistance are driven by complex biological, molecular, and ecological forces, creating a constantly shifting landscape that challenges modern oncology. Understanding and intervening in this complexity requires integrating evolutionary biology, tumor ecosystem analysis, and state-of-the-art technologies together with novel approaches of precision oncology. The scientific program of the 66th Annual Meeting of the Italian Cancer Society is designed to reflect this conceptual shift and bring together clinical and preclinical researcher to discuss the most novel and compelling evidences that might help in designing more active and less toxic treatments. The meeting will be therefore of interest for both preclinical and clinical researchers, working in different areas of cancer research. Over three days the scientific program will see the participation of Italian and foreign world-renowned scientist to integrate clinical and preclinical presentations on different pathologies including but not limited to women (breast and gynecological), gastrointestinal, prostate, lung and pancreatic cancers. This meeting brings together evolutionary biology, technology, and clinical innovation to redefine how we understand and treat cancer. We will examine tumor evolution and ecosystems, revealing how microenvironmental pressures shape heterogeneity, immune escape, metastasis, and resistance. We will showcase transformative technologies — multimodal AI, spatial omics, digital twins, liquid biopsies, and advanced imaging — that are reshaping how cancer is mapped, modeled, and predicted, accelerating translation to the clinic. Finally, we will discuss of precision oncology, focusing on adaptive therapies, rational combinations, and biomarker-driven strategies that exploit tumor vulnerabilities uncovered by evolutionary and multi-omic insights. On the opening day SIC will hold an open session dedicated to survivors, patients, caregivers and all stakeholders involved in the cancer care. In an interactive round table, it will be discussed why and how research can impact on cancer prevention, treatment and patients' quality of life.

Luogo

Centro Congressi Europa, Università Cattolica
Largo Francesco Vito 1, Roma (RM)

Programma

Wednesday, October 7th· Centro Congressi Europa, Università Cattolica, Largo Francesco Vito 1, Roma
  • 9.30–10.30Registration
  • 13.30–14.00Opening Address
  • 14.00–14.30Opening Lecture – Evolutionary characterisation of lung cancer metastasisMariam Jamal-Hanjani
  • 14.30–16.00Lecture 1: When mistranslation meets cancer immunotherapyReuven Agami
  • 15.00–15.15Selected abstract 1
  • 15.15–15.30Selected abstract 2
  • 15.30–16.00Lecture 2: Integrating multiple dimensions to understand cancer evolutionElisa Oricchio
  • 17.00–17.30Coffee Break
  • 17.30–19.00The EMBO Keynote Lecture – Lecture 3: Metabolic & Epigenetic Control of Cancer ImmunityMassimiliano Mazzone
  • 18.00–18.15Selected abstract 3
  • 18.15–18.30Selected abstract 4
  • 18.30–19.00Lecture 4: Fibroblast remodeling in inflammation and cancerRuth Scherz-Shouval
Thursday, October 8th· Centro Congressi Europa, Università Cattolica, Roma
  • 10.30–12.00Lecture 5: Decoding Tumour Ecosystems through Spatial Multi-Omics and Self-Supervised AIJohn Le Quesne
  • 11.00–11.15Selected abstract 5
  • 11.15–11.30Selected abstract 6
  • 11.30–12.00Lecture 6: Tracking cancer initiation in the kidney via somatic mutation analysis of normal cellsIrene Franco
  • 13.15–14.45Lunch
  • 16.15–17.00PRODI LECTURE – Paolo Di FiorePier Paolo Di Fiore
  • 17.00–17.30Coffee Break
  • 17.30–19.00Lecture 9: Functionalizing tumor complexity in pancreatic cancerGiannicola Genovese
  • 18.00–18.15Selected abstract 9
  • 18.15–18.30Selected abstract 10
  • 18.30–19.00Lecture 10: From Molecular Landscape to Clinical Precision: Navigating Colorectal Cancer Subtypes and Therapeutic FrontiersErica Martinelli
Friday, October 9th· Centro Congressi Europa, Università Cattolica, Roma
  • 8.00–9.00Registration
  • 9.00–10.30Lecture 11: Implementation of ctDNA testing in clinical and translational researchNicola Normanno
  • 9.30–9.45Selected abstract 11
  • 9.45–10.00Selected abstract 12
  • 10.00–10.30Lecture 12: CtDNA in localized colon cancer: scientifically sound or clinically useful?Chiara Cremolini
  • 10.30–11.00Coffee break
  • 12.30–13.45Lunch
  • 16.15–16.45Closing Lecture – Extrachromosomal DNA (ecDNA): Cancer's Dynamic Circular GenomePaul Salomon Mischel
  • 16.45–17.00Closing Remarks

Responsabili del corso

MEETING SRL

Provider

ID Provider: N° 7194

Città: Udine (UD)

Tipologia: Società, Agenzie Ed Enti Privati

Stato accreditamento: Standard

  • Dott. Carmine Carbone

    Responsabile scientifico

    Specializzazione: Oncologia Medica

    Struttura: IRCCS Fondazione Policlinico Universitario Agostino Gemelli

    Ruolo: Research Scientist, Medical Oncology

Domande frequenti

L'evento è accreditato per: Veterinario (Igiene Prod., Trasf., Commercial., Conserv. E Tras. Alimenti Di Origine Animale E Derivati); Chimico (Chimica); Biologo (Biologo); Veterinario (Sanità Animale); Fisico (Fisica); Tecnico Sanitario Laboratorio Biomedico (Tecnico Sanitario Laboratorio Biomedico).

Fonte dati per questo evento: Agenas. Evento organizzato da provider terzo. Smart ECM riporta dati pubblici dell'evento a scopo informativo e non è responsabile né del corso né dei contenuti, né ha accordi commerciali o di collaborazione con il provider.

Sei un provider ECM?

Contattaci per scoprire come possiamo collaborare.

Contattaci